Clinical Trial

Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated July 30, 2024 (before its estimated January 2025 completion). Its status may not reflect the trial's current state.
Summary
Assessment of cardiovascular disorders using echocardiography and arterial stiffness; comparative noninvasive assessment of volatile organic compound (eVOC) exhale breath patterns in patients with different chronic respiratory diseases with age and gender-matched healthy adults in order to identify a disease-specific exhaled eVOCs profiles and markers of respiratory and cardiovascular disorders.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-02-06.
Trial Details
NCT Number NCT05727852
Lead Sponsor I.M. Sechenov First Moscow State Medical University
Conditions Chronic Respiratory Diseases, Cystic Fibrosis, Lymphangioleiomyomatosis, Hypersensitivity Pneumonitis, Interstitial Lung Diseases, COPD, Bronchial Asthma
Enrollment 400 participants
Start Date 2023-01-30
Primary Completion 2025-01 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-07-30